Cargando…

Taurine and Methylprednisolone Administration at Close Proximity to the Onset of Muscle Degeneration Is Ineffective at Attenuating Force Loss in the Hind-Limb of 28 Days Mdx Mice

An increasing number of studies have shown supplementation with the amino acid taurine to have promise in ameliorating dystrophic symptoms in the mdx mouse model of Duchenne Muscular Dystrophy (DMD). Here we build on this limited body of work by investigating the efficacy of supplementing mdx mice w...

Descripción completa

Detalles Bibliográficos
Autores principales: Barker, Robert G., van der Poel, Chris, Horvath, Deanna, Murphy, Robyn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315906/
https://www.ncbi.nlm.nih.gov/pubmed/30274388
http://dx.doi.org/10.3390/sports6040109
_version_ 1783384404774617088
author Barker, Robert G.
van der Poel, Chris
Horvath, Deanna
Murphy, Robyn M.
author_facet Barker, Robert G.
van der Poel, Chris
Horvath, Deanna
Murphy, Robyn M.
author_sort Barker, Robert G.
collection PubMed
description An increasing number of studies have shown supplementation with the amino acid taurine to have promise in ameliorating dystrophic symptoms in the mdx mouse model of Duchenne Muscular Dystrophy (DMD). Here we build on this limited body of work by investigating the efficacy of supplementing mdx mice with taurine postnatally at a time suggestive of when dystrophic symptoms would begin to manifest in humans, and when treatments would likely begin. Mdx mice were given either taurine (mdx tau), the steroid alpha methylprednisolone (PDN), or tau + PDN (mdx tau + PDN). Taurine (2.5% wt/vol) enriched drinking water was given from 14 days and PDN (1 mg/kg daily) from 18 days. Wild-type (WT, C57BL10/ScSn) mice were used as a control to mdx mice to represent healthy tissue. In the mdx mouse, peak damage occurs at 28 days, and in situ assessment of contractile characteristics showed that taurine, PDN, and the combined taurine + PDN treatment was ineffective at attenuating the force loss experienced by mdx mice. Given the benefits of taurine as well as methylprednisolone reported previously, when supplemented at close proximity to the onset of severity muscle degeneration these benefits are no longer apparent.
format Online
Article
Text
id pubmed-6315906
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63159062019-01-10 Taurine and Methylprednisolone Administration at Close Proximity to the Onset of Muscle Degeneration Is Ineffective at Attenuating Force Loss in the Hind-Limb of 28 Days Mdx Mice Barker, Robert G. van der Poel, Chris Horvath, Deanna Murphy, Robyn M. Sports (Basel) Article An increasing number of studies have shown supplementation with the amino acid taurine to have promise in ameliorating dystrophic symptoms in the mdx mouse model of Duchenne Muscular Dystrophy (DMD). Here we build on this limited body of work by investigating the efficacy of supplementing mdx mice with taurine postnatally at a time suggestive of when dystrophic symptoms would begin to manifest in humans, and when treatments would likely begin. Mdx mice were given either taurine (mdx tau), the steroid alpha methylprednisolone (PDN), or tau + PDN (mdx tau + PDN). Taurine (2.5% wt/vol) enriched drinking water was given from 14 days and PDN (1 mg/kg daily) from 18 days. Wild-type (WT, C57BL10/ScSn) mice were used as a control to mdx mice to represent healthy tissue. In the mdx mouse, peak damage occurs at 28 days, and in situ assessment of contractile characteristics showed that taurine, PDN, and the combined taurine + PDN treatment was ineffective at attenuating the force loss experienced by mdx mice. Given the benefits of taurine as well as methylprednisolone reported previously, when supplemented at close proximity to the onset of severity muscle degeneration these benefits are no longer apparent. MDPI 2018-09-30 /pmc/articles/PMC6315906/ /pubmed/30274388 http://dx.doi.org/10.3390/sports6040109 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Barker, Robert G.
van der Poel, Chris
Horvath, Deanna
Murphy, Robyn M.
Taurine and Methylprednisolone Administration at Close Proximity to the Onset of Muscle Degeneration Is Ineffective at Attenuating Force Loss in the Hind-Limb of 28 Days Mdx Mice
title Taurine and Methylprednisolone Administration at Close Proximity to the Onset of Muscle Degeneration Is Ineffective at Attenuating Force Loss in the Hind-Limb of 28 Days Mdx Mice
title_full Taurine and Methylprednisolone Administration at Close Proximity to the Onset of Muscle Degeneration Is Ineffective at Attenuating Force Loss in the Hind-Limb of 28 Days Mdx Mice
title_fullStr Taurine and Methylprednisolone Administration at Close Proximity to the Onset of Muscle Degeneration Is Ineffective at Attenuating Force Loss in the Hind-Limb of 28 Days Mdx Mice
title_full_unstemmed Taurine and Methylprednisolone Administration at Close Proximity to the Onset of Muscle Degeneration Is Ineffective at Attenuating Force Loss in the Hind-Limb of 28 Days Mdx Mice
title_short Taurine and Methylprednisolone Administration at Close Proximity to the Onset of Muscle Degeneration Is Ineffective at Attenuating Force Loss in the Hind-Limb of 28 Days Mdx Mice
title_sort taurine and methylprednisolone administration at close proximity to the onset of muscle degeneration is ineffective at attenuating force loss in the hind-limb of 28 days mdx mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315906/
https://www.ncbi.nlm.nih.gov/pubmed/30274388
http://dx.doi.org/10.3390/sports6040109
work_keys_str_mv AT barkerrobertg taurineandmethylprednisoloneadministrationatcloseproximitytotheonsetofmuscledegenerationisineffectiveatattenuatingforcelossinthehindlimbof28daysmdxmice
AT vanderpoelchris taurineandmethylprednisoloneadministrationatcloseproximitytotheonsetofmuscledegenerationisineffectiveatattenuatingforcelossinthehindlimbof28daysmdxmice
AT horvathdeanna taurineandmethylprednisoloneadministrationatcloseproximitytotheonsetofmuscledegenerationisineffectiveatattenuatingforcelossinthehindlimbof28daysmdxmice
AT murphyrobynm taurineandmethylprednisoloneadministrationatcloseproximitytotheonsetofmuscledegenerationisineffectiveatattenuatingforcelossinthehindlimbof28daysmdxmice